LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-2.81 | ₹2.24 | ₹-0.75 | ₹-4.30 | ₹13.59 |
What is the latest Earnings Per Share (EPS) of LYKA LABS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹-2.81 |
| Mar2025 | ₹2.24 |
| Mar2024 | ₹-0.75 |
| Mar2023 | ₹-4.30 |
| Mar2022 | ₹13.59 |
How is Earnings Per Share (EPS) of LYKA LABS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2.81 | Negative | |
| Mar2025 | ₹2.24 | Positive | |
| Mar2024 | ₹-0.75 | Negative | |
| Mar2023 | ₹-4.30 | Negative | |
| Mar2022 | ₹13.59 | - | |
Compare Earnings Per Share (EPS) of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹216.7 Cr | -5.2% | -19.5% | -45.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -5.2% |
-19.5% |
-45.4% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses